↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "LAR1:lu ;conttype:(refereed);pers:(Borrebaeck Carl)"

Search: LAR1:lu > Peer-reviewed > Borrebaeck Carl

Result 21-30 of 279

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
21.	Borrebaeck, Carl, et al. (author) Antibody array generation and use. 2014 In: Methods in Molecular Biology. - Totowa, NJ : Humana Press. - 1940-6029. ; 1131, s. 563-571 Journal article (peer-reviewed)abstract Affinity proteomics, represented by antibody arrays, is a multiplex technology for high-throughput protein expression profiling of crude proteomes in a highly specific, sensitive, and miniaturized manner. The antibodies are individually deposited in an ordered pattern, an array, onto a solid support. Next, the sample is added, and any specifically bound proteins are detected and quantified using mainly fluorescence as the mode of detection. The binding pattern is then converted into a relative protein expression map, or protein atlas, delineating the composition of the sample at the molecular level. The technology provides unique opportunities for various applications, such as protein expression profiling, biomarker discovery, disease diagnostics, prognostics, evidence-based therapy selection, and disease monitoring. Here, we describe the generation and use of planar antibody arrays for serum protein profiling.
22.	Borrebaeck, Carl, et al. (author) Antibody evolution beyond nature 2002 In: Nature Biotechnology. - : Springer Science and Business Media LLC. - 1546-1696 .- 1087-0156. ; 20:12, s. 1189-1190 Journal article (peer-reviewed)
23.	Borrebaeck, Carl (author) Antibody microarray-based oncoproteomics 2006 In: Expert Opinion on Biological Therapy. - : Informa Healthcare. - 1471-2598 .- 1744-7682. ; 6:8, s. 833-838 Journal article (peer-reviewed)abstract The driving force behind oncoproteomics is the belief that certain protein signatures or patterns exist that are associated with a particular malignancy. if so, the correlation of clinical parameters with defined protein expression patterns would allow us to predict disease progression and perhaps even postulate improved therapeutic modalities. The technological challenges to achieve these goals are significant, as the human proteome is not defined. No general methodological approach exists today, and human cancer can, furthermore, be divided into several disease subgroups. One potential solution to finding cancer-associated protein signatures is the emerging technology of affinity proteomics. This approach addresses some of the shortcomings of traditional proteomics and combines it with the power of microarrays. The present review focuses on the role of antibody microarrays in oncoproteomics and its potential to provide a truly proteome-wide analytical approach.
24.	Borrebaeck, Carl (author) Antibody microarray based oncoproteomics - State-of-the-Art Lecture 2006 Conference paper (peer-reviewed)
25.	Borrebaeck, Carl (author) Antibody microarray in proteome analysis: A drug discovery tool? 2003 Conference paper (peer-reviewed)
26.	Borrebaeck, Carl (author) Antibody microarrays – developing a tool for high-throughput proteomics 2003 In: ; , s. 47-48 Conference paper (peer-reviewed)
27.	Borrebaeck, Carl (author) Antibody microarrays for cancer proteome analysis (Key note speaker) 2006 Conference paper (peer-reviewed)
28.	Borrebaeck, Carl (author) Antibody microarrays for cancer proteome profiling 2005 Conference paper (peer-reviewed)
29.	Borrebaeck, Carl (author) Antibody Microarrays in Proteomics – Pros and Cons 2002 Conference paper (peer-reviewed)
30.	Borrebaeck, Carl, et al. (author) Antibody microarrays: technology and analysis if serum proteomes from cancer patients 2006 In: Human Antibodies. - 1093-2607. ; 15:1-2, s. 34-34 Conference paper (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 21-30 of 279

Refine your search

Type of publication: journal article (173); conference paper (88); research review (12); book chapter (6)

Type of content: peer-reviewed (279)Undo refine

Author/Editor: Borrebaeck, Carl (240)Undo refine; Wingren, Christer (104); Lindstedt, Malin (39); Borrebaeck, Carl A K (37); Ingvarsson, Johan (33); Ohlin, Mats (31); show more...; Ek, Sara (26); Ellmark, Peter (25); Carlsson, Anders (21); Lundberg, Kristina (11); Larsson, Kristina (10); Furebring, Christina (10); Jerkeman, Mats (9); Greiff, Lennart (9); Carlsson, Roland (9); Dictor, Michael (9); Uhlén, Mathias (8); Jirström, Karin (8); Andreasson, Ulrika (8); Axelsson, Ulrika (8); Malmborg Hager, Ann ... (8); Fernö, Mårten (7); Johansson, Henrik (7); Laurell, Thomas (7); James, Peter (7); Rydén, Lisa (6); Sturfelt, Gunnar (6); Marko-Varga, György (6); Johansson-Lindbom, B ... (6); Högerkorp, Carl-Magn ... (6); Persson, Helena (6); Wahren, Britta (6); Danielsson, Lena (6); Karlsson, Fredrik (5); Olsson, Håkan (5); Baldetorp, Bo (5); Albrekt, Ann-Sofie (5); Nordström, Malin (5); Ohlsson, Mattias (4); Salford, Leif (4); Bjartell, Anders (4); Hansson, Stefan (4); Korsgren, Magnus (4); Johnsson, Per (4); Peterson, Carsten (4); Jansson, Bo (4); Ingvarsson, Sigurdur (4); Broos, Sissela (4); Gustavsson, Elin (4); Persson, Oscar (4); show less...

University: Lund University (279); Royal Institute of Technology (11); Karolinska Institutet (11); Uppsala University (10); University of Gothenburg (4); Chalmers University of Technology (3); show more...; RISE (3); Linköping University (2); Swedish University of Agricultural Sciences (1); show less...

Language: English (278); Swedish (1)

Research subject (UKÄ/SCB): Medical and Health Sciences (253); Natural sciences (27); Engineering and Technology (15); Agricultural Sciences (3)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view